Gemcitabine and cisplatin-based combination chemotherapy in advanced hepatocellular carcinoma: An Indian experience

BACKGROUND: Gemcitabine, an anti-metabolite, has some activity in hepatocellular carcinoma (HCC) in terms of responses and median survival. AIMS: To analyze our experience with the use of gemcitabine in combination with cisplatin in HCC with respect to response, toxicity and survival. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Pande, Shripad B., Doval, D. C., Pavithran, K., Sharma, J. B., Shirali, Rashmi, Jena, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385278/
https://www.ncbi.nlm.nih.gov/pubmed/22754208
http://dx.doi.org/10.4103/0971-5851.96968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385278/
https://www.ncbi.nlm.nih.gov/pubmed/22754208
http://dx.doi.org/10.4103/0971-5851.96968

Ejemplares similares